Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNA

This study has been completed.
Sponsor:
Collaborator:
Pusan National University Hospital
Information provided by (Responsible Party):
Sang Hoon Ahn, Yonsei University
ClinicalTrials.gov Identifier:
NCT00625560
First received: February 11, 2008
Last updated: May 7, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2010
  Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)